Search 33,000+ CME courses
Back

StatPearls, LLC

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Hand Strength
  • Inflammatory Bowel Diseases
  • Sulfasalazine

Sulfasalazine

Sulfasalazine, a potent disease-modifying antirheumatic drug (DMARD), helps manage autoimmune conditions like rheumatoid arthritis and inflammatory bowel disease. This activity discusses sulfasalazine’s therapeutic indications, contraindications, and mechanism of action, crucial elements indispensable for the interdisciplinary team involved in patient care. Moreover, the activity focuses on adverse events and other essential facets of sulfasalazine therapy, ensuring healthcare professionals can navigate its complexities to optimize patient outcomes. By exploring off-label applications, pharmacokinetics, monitoring protocols, and clinical toxicology, participants gain an excellent grasp of sulfasalazine’s utility, enabling them to tailor treatment strategies for individuals with inflammatory bowel disease, rheumatoid arthritis, and polyarticular juvenile idiopathic arthritis. With this understanding, healthcare practitioners can fine-tune therapeutic regimens to meet diverse patient needs, enhancing sulfasalazine therapy’s efficacy and precision across various clinical contexts.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABOS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

More from StatPearls, LLC

See all

This provider’s courses closest to this one